← Back to Clinical Trials
Recruiting NCT04109235

NCT04109235 Family Health Team High-Intensity Interval Training

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04109235
Status Recruiting
Phase
Sponsor Western University, Canada
Condition Type 2 Diabetes
Study Type INTERVENTIONAL
Enrollment 20 participants
Start Date 2020-02-13
Primary Completion 2026-07-13

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
High-Intensity Interval Training Physical Activity (PA) AdvicePopulation-Based Physical Activity (PA) Advice

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 20 participants in total. It began in 2020-02-13 with a primary completion date of 2026-07-13.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

With the rapid shift to virtual care, this pilot study aims to determine the feasibility of prescribing low-duration, interval-based training through virtual care. If successful, this study will inform a larger randomized control trial to determine if the prescription of low-duration interval-based training improves chronic disease through the measurement of hemoglobin A1C (HbA1C), and weight to a greater extent than the general guideline to aim for 150 minutes of PA weekly.

Eligibility Criteria

Inclusion Criteria: * adults, at least 18 years of age * non-pregnant * having a diagnosis of type 2 diabetes in accordance with the 2018 Diabetes Canada Clinical Practice Guidelines * capable of consenting * deemed capable and safe to exercise by their physician (Dr. Fernando) * without a medical history of myocardial infarction in the past three months. Exclusion Criteria: * \< 18 years of age * pregnant * not having a type 2 diabetes diagnosis * having a medical history of myocardial infarction in the past 3 months

Contact & Investigator

Central Contact

Michael Fernando, MD

✉ mfernando@eefht.ca

📞 519-773-3715

Frequently Asked Questions

Who can join the NCT04109235 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Type 2 Diabetes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT04109235 currently recruiting?

Yes, NCT04109235 is actively recruiting participants. Contact the research team at mfernando@eefht.ca for enrollment information.

Where is the NCT04109235 trial being conducted?

This trial is being conducted at Aylmer, Canada.

Who is sponsoring the NCT04109235 clinical trial?

NCT04109235 is sponsored by Western University, Canada. The trial plans to enroll 20 participants.

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology